...
首页> 外文期刊>Magnetic resonance imaging: An International journal of basic research and clinical applications >Microstructure abnormity in the optic nerve of type 1 diabetic rats revealed by diffusion tensor imaging study
【24h】

Microstructure abnormity in the optic nerve of type 1 diabetic rats revealed by diffusion tensor imaging study

机译:由扩散张量成像研究揭示1型糖尿病大鼠视神经中的微观结构异常

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Diabetic retinopathy (DR) is one of a major complication of type 1 diabetes mellitus (T1DM) and a leading cause of blindness. Evidence of animal study has shown that it is not only a microvasucular lesion of the eye, but also a neurodegeneration disease of the visual system. However, the in vivo imaging evidence of axonal degeneration in the diabetic optic nerve is scarce. Diffusion tensor imaging (DTI) technique has been proved to be an effective tool to track the integrity of the nerve fibers in the central nervous system. In this study, type 1 diabetes was induced by intraperitoneally injecting a single dose of streptozotocin (STZ) into Sprague-Dawley rats. DTI combined with histological assessments was carried out on the optic nerve to clarify the microstructural alterations underlying DTI indices changes at 4 weeks (4 w), 8 weeks (8 w) and 12 weeks (12 w) after STZ induction. The retinal changes were analyzed by pathological evaluations at 4 weeks (4 w) and 12 weeks (12 w) after STZ induction. DTI results showed significantly decreased mean diffusivity (MD) and axial diffusivity (Da) in diabetic optic nerve compared to controls at 12 w. Atrophy in diabetic nerves was monitored by high resolution T 2 -weighted images. Axonal degeneration without myelin loss of the optic nerve was confirmed by histological examination. Moreover, there are positive correlations between decreased diffusivities (MD and Da) in the optic nerve and reduced total axolemmal area. The diabetic rats showed intense glial activity since 4 w and thinning of the thickness in inner plexiform layer and nerve fiber layer at 12 w in the retina. In conclusion, DTI could in vivo monitor the progression of optic nerve degeneration in diabetes and the findings in our study would help supply axonal protection for DR in preclinical practice.
机译:糖尿病视网膜病变(DR)是1型糖尿病(T1DM)的主要并发症之一,以及盲目的主要原因。动物研究的证据表明,它不仅是眼睛的微脱裂病变,而且是视觉系统的神经变性疾病。然而,糖尿病视神经中轴突变性的体内成像证据是稀缺的。已经证明了扩散张量成像(DTI)技术是追踪中枢神经系统中神经纤维的完整性的有效工具。在该研究中,通过腹膜内注射单剂量的链脲佐菌素(STZ)进入Sprague-Dawley大鼠来诱导1型糖尿病。 DTI与组织学评估结合在视神经上进行,以阐明DTI指数下面的微观结构改变在STZ诱导后4周(4 W),8周(8 W)和12周(12 W)变化。通过4周(4 W)和12周(12 W)在STZ诱导后分析视网膜变化。与12W的对照相比,DTI结果表明,糖尿病视神经中的平均扩散性(MD)和轴向扩散性(DA)显着降低。通过高分辨率T 2 - 重量的图像监测糖尿病神经中的萎缩。没有组织学检查确认没有髓鞘损失的轴突变性。此外,在视神经中减少的扩散性(MD和DA)之间存在正相关性,并且减少总腋液区域。糖尿病大鼠由于4W以来显示出强神经胶质活性,并且在视网膜中12W在内络合物层和神经纤维层中稀疏。总之,DTI可以在体内监测糖尿病中视神经变性的进展,我们研究中的研究结果将有助于在临床前实践中为DR提供轴突保护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号